Untitled

Thyroid Gland

  • Also known as thyroid follicle cells
    • The Functional cell
  • The thyroid produces less T3 than T4, but T3 has a much greater effect on metabolism than T4.
1. T4 - Tetraiodothyronine / Thyroxine
  • Definition: A butterfly-shaped organ located in the lower neck, anterior to the trachea.
  • Dimensions and Weight: The gland is about 5 cm long and 3 cm wide, weighing about 30 g.
  • Physical Examination: Easily palpated during physical examination.
  • Structure: Consists of two lobes joined by a central mass, or isthmus.
2. Physiology
  • Functional Unit: Thyrocytes
  • Hormone Production: Inside is thyroglobulin that binds to iodide to become hormones T3 and T4.
    • Process of Hormone Formation:
    • MIT + MIT = Diodothyronine (DIT)
    • MIT + DIT = Triiodothyronine (T3)
    • DIT + DIT / MIT + T3 = Tetraiodothyronine (T4)
3. Hormones
  • 1. T3 - Triiodothyronine: This is the primary hormone your thyroid makes and releases.
    • Although your thyroid makes the most of this hormone, it doesn’t have much effect on your metabolism.
    • Once released into your bloodstream, T4 can convert to T3 through a process called deiodination.
  • 2. Calcitonin:
    • Blocks the activity of osteoclasts, which are cells that break down bone.
    • Reduces the amount of calcium that enters your blood by temporarily blocking osteoclast activity.
  • 3. TSH - Thyroid Stimulating Hormone:
    • Also referred to as thyrotropin, it is released by the pituitary gland to trigger the thyroid to produce T4 and T3.
  • 4. Calcitonin (again):
    • Hormone that regulates calcium levels in the blood by decreasing calcium.
    • Opposes the action of parathyroid hormone, which increases blood calcium levels.
Additional Information
  • The pituitary gland releases TSH through the anterior lobes (glandular tissue).

Hyperthyroidism

Usual Results:

  • T3 and T4: Increase
  • TSH: Decrease
Definition
  • Hyperthyroid state resulting from hypersecretion of thyroid hormones (T3 and T4).
  • Characterized by an increased rate of body metabolism.
  • Common Cause: Grave’s Disease (toxic diffuse goiter).
  • Clinical manifestations are referred to as thyrotoxicosis.
Assessment
  • Personality changes: irritability, agitation, and mood swings.
  • Nervousness; fine tremors of the hands.
  • Weakness; muscle aches; paresthesias.
  • Heat intolerance; weight loss.
  • Smooth, soft skin and hair.
  • Palpitations; cardiac dysrhythmias (e.g., tachycardia or atrial fibrillation).
  • Diarrhea; exophthalmos (bulge eyes); diaphoresis (excessive sweating).
  • Hypertension; enlarged thyroid gland (goiter).
Interventions
  1. Provide adequate rest.
  2. Administer sedatives as prescribed.
  3. Provide a cool and quiet environment.
  4. Obtain daily weight.
  5. Provide a high-calorie diet.
  6. Avoid stimulants.
  7. Administer antithyroid medications (e.g., Methimazole or Propylthiouracil) that block thyroid synthesis as prescribed.
  8. Administer iodine preparations that inhibit the release of thyroid hormone as prescribed.
  9. Administer propranolol for tachycardia as prescribed.
  10. Prepare the client for radioactive iodine therapy to destroy thyroid cells.
  11. Prepare the client for subtotal thyroidectomy if prescribed.
  12. Elevate the head of the bed for clients with exophthalmos; instruct on low-salt diet; administer artificial tears; encourage the use of dark glasses; and tape eyelids closed at night if necessary.
  13. Allow the client to express concerns about body image changes.
Additional Information
  • Pregnancy Consideration: PTU is used during the 1st trimester to avoid risks for babies if exposed to methimazole. Methimazole is used in the 2nd and 3rd trimesters due to PTU’s hepatotoxicity.
  • Both PTU and Methimazole inhibit the synthesis of iodide and thyroglobulin in hormone formation.
  • During RAI therapy, patients must avoid close contact with pregnant women, children, and the elderly and maintain isolation. Pointers include double flushing, double covering used linens, and avoiding it in patients with kidney problems.
  • Thyroidectomy is the surgical removal of the thyroid.
Grave’s Disease
  • Definition: An immune system disorder causing overproduction of thyroid hormones (hyperthyroidism).
  • Mechanism: Antibody TRAb overrides normal thyroid regulation, leading to increased production of T3 and T4. TRAb identifies itself as TSH prompting excessive hormone production.
Toxic Nodular Goiter
  • Definition: Involves an enlarged thyroid with nodules producing excessive thyroid hormone.
  • Occurrence: Arises from a prolonged simple goiter, primarily seen in the elderly. Symptoms resemble hyperthyroidism but do not typically include exophthalmos. Risk factors include age (over 60 years old) and female gender.

Hypothyroidism

Usual Results:

  • T3 and T4: Decrease
  • TSH: Increase
Definition
  • Resulting from hyposecretion of thyroid hormones.
  • Characterized by decreased body metabolism rate.
  • T3 and T4 levels are low, while TSH levels are elevated.
  • Primary Hypothyroidism: The thyroid itself has dysfunction.
  • Secondary Hypothyroidism: Lack of stimulation by the pituitary gland.
Additional Information
  • Primary originates from the thyroid; secondary from the pituitary gland.
Assessment
  • Common symptoms include lethargy, fatigue, weakness, muscle aches, paresthesias; cold intolerance; weight gain; dry skin and hair; bradycardia; constipation; edema (myxedema); forgetfulness; menstrual disturbances; possible goiter presence; cardiac enlargement; propensity for heart failure.
Interventions
  1. Monitor vital signs, particularly heart rate and rhythm.
  2. Administer thyroid replacement therapy (Levothyroxine Sodium is most common).
  3. Educate the client about the therapy’s clinical manifestations for both under- and over-replacement.
  4. Recommend low-calorie, low-cholesterol, low-saturated fat diet and discuss daily exercise (e.g. walking).
  5. Assess for constipation and provide fiber and fluids.
  6. Ensure a warm environment for the client.
  7. Avoid sedatives and opioids due to increased sensitivity and potential myxedema coma risk.
  8. Monitor for signs of thyroid medication overdose characterized by tachycardia, chest pain, restlessness, nervousness, and insomnia.
  9. Instruct reporting of chest pain or overdose signs immediately.
Additional Information
  • Levothyroxine Sodium: A lifelong medication that takes 6-8 weeks to be effective. Instructions include:
    • Lifelong use
    • Long acting
    • Early morning intake (30 mins before breakfast)
    • Very active
    • Safe for pregnant women (good for baby).

Hashimoto's Disease

  • Also known as Hashimoto thyroiditis, part of autoimmune thyroid diseases (AITDs), characterized by immune-mediated destruction of thyroid cells. The treatment aims for thyroid hormone replacement, typically with levothyroxine sodium, for life.

Myxedema Coma

  • Results from persistently low thyroid production, potentially precipitated by factors such as acute illness, rapid withdrawal of medication, anesthesia, hypothermia, or certain medications.
Assessment
  • Includes hypotension, bradycardia, hypothermia, hyponatremia, hypoglycemia, generalized edema, respiratory failure, and coma.
Interventions
  1. Maintain a patent airway.
  2. Implement aspiration precautions.
  3. Administer IV fluids (normal or hypertonic saline).
  4. Provide IV Levothyroxine Sodium as prescribed.
  5. Give intravenous glucose as required.
  6. Administer corticosteroids as prescribed.
  7. Monitor temperature hourly.
  8. Frequent blood pressure monitoring.
  9. Warm the client.
  10. Assess for changes in mental status.
  11. Monitor electrolyte and glucose levels.